Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Influenza and Other Respiratory Viruses
|
May 21, 2025
COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024-January 2025, VEBIS Primary Care Network
Charlotte Laniece Delaunay, Nuno Verdasca, Susana Monge, et al.
Vaccine
|
July 6, 2024
Corrigendum to "Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: results from the VEBIS primary care test-negative design study, September 2023-January 2024" [Vaccine 42(19) (2024)]
Charlotte Laniece Delaunay, Aryse Melo, Marine Maurel, et al.
Influenza and Other Respiratory Viruses
|
November 11, 2024
Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023-1 March 2024
Lore Merdrignac, Charlotte Laniece Delaunay, Nuno Verdasca, et al.
Vaccine
|
June 5, 2024
Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023-January 2024
Charlotte Laniece Delaunay, Aryse Melo, Marine Maurel, et al.
Emerging Infectious Diseases
|
March 23, 2023
Adeno-Associated Virus 2 and Human Adenovirus F41 in Wastewater during Outbreak of Severe Acute Hepatitis in Children, Ireland
Niamh A Martin, Gabriel Gonzalez, Liam J Reynolds, et al.
Expert Review of Vaccines
|
March 12, 2026
Vaccine effectiveness against medically-attended, laboratory-confirmed influenza in the I-MOVE primary care network in Europe, VEBIS project, 2024/25
Héloïse Lucaccioni, Francisco Pozo, Gloria Pérez-Gimeno, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
June 13, 2025
Influenza vaccine effectiveness in Europe and the birth cohort effect against influenza A(H1N1)pdm09: VEBIS primary care multicentre study, 2023/24
Esther Kissling, Marine Maurel, Francisco Pozo, et al.
JAMA Network Open
|
July 1, 2024
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans
Charlotte Laniece Delaunay, Clara Mazagatos, Iván Martínez-Baz, et al.
Influenza and Other Respiratory Viruses
|
January 11, 2024
Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study
Marine Maurel, Francisco Pozo, Gloria Pérez-Gimeno, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
March 29, 2024
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022
Charlotte Lanièce Delaunay, Iván Martínez-Baz, Noémie Sève, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Influenza and Other Respiratory Viruses
|
May 21, 2025
COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024-January 2025, VEBIS Primary Care Network
Charlotte Laniece Delaunay, Nuno Verdasca, Susana Monge, et al.
Vaccine
|
July 6, 2024
Corrigendum to "Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: results from the VEBIS primary care test-negative design study, September 2023-January 2024" [Vaccine 42(19) (2024)]
Charlotte Laniece Delaunay, Aryse Melo, Marine Maurel, et al.
Influenza and Other Respiratory Viruses
|
November 11, 2024
Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023-1 March 2024
Lore Merdrignac, Charlotte Laniece Delaunay, Nuno Verdasca, et al.
Vaccine
|
June 5, 2024
Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023-January 2024
Charlotte Laniece Delaunay, Aryse Melo, Marine Maurel, et al.
Emerging Infectious Diseases
|
March 23, 2023
Adeno-Associated Virus 2 and Human Adenovirus F41 in Wastewater during Outbreak of Severe Acute Hepatitis in Children, Ireland
Niamh A Martin, Gabriel Gonzalez, Liam J Reynolds, et al.
Expert Review of Vaccines
|
March 12, 2026
Vaccine effectiveness against medically-attended, laboratory-confirmed influenza in the I-MOVE primary care network in Europe, VEBIS project, 2024/25
Héloïse Lucaccioni, Francisco Pozo, Gloria Pérez-Gimeno, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
June 13, 2025
Influenza vaccine effectiveness in Europe and the birth cohort effect against influenza A(H1N1)pdm09: VEBIS primary care multicentre study, 2023/24
Esther Kissling, Marine Maurel, Francisco Pozo, et al.
JAMA Network Open
|
July 1, 2024
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans
Charlotte Laniece Delaunay, Clara Mazagatos, Iván Martínez-Baz, et al.
Influenza and Other Respiratory Viruses
|
January 11, 2024
Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study
Marine Maurel, Francisco Pozo, Gloria Pérez-Gimeno, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
March 29, 2024
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022
Charlotte Lanièce Delaunay, Iván Martínez-Baz, Noémie Sève, et al.
Page
of 3